Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

NCT01358253 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Rituximab
DRUG: 6-Mercaptopurine
DRUG: Prednisone
DRUG: L-asparaginase

Sponsor

Ruijin Hospital